Connect with us

International

New findings on hair loss in men

A receding hairline, a total loss of hair from the crown, and ultimately, the classical horseshoe-shaped pattern of baldness: Previous research into male…

Published

on

A receding hairline, a total loss of hair from the crown, and ultimately, the classical horseshoe-shaped pattern of baldness: Previous research into male pattern hair loss, also termed androgenetic alopecia, has implicated multiple common genetic variants. Human geneticists from the University Hospital of Bonn (UKB) and by the Transdisciplinary Research Unit “Life & Health” of the University of Bonn have now performed a systematic investigation of the extent to which rare genetic variants may also contribute to this disorder. For this purpose, they analyzed the genetic sequences of 72,469 male participants from the UK Biobank project. The analyses identified five significantly associated genes, and further corroborated genes implicated in previous research. The results have now been published in the prestigious scientific journal Nature Communications.

Credit: University Hospital Bonn / Katharina Wislsperger

A receding hairline, a total loss of hair from the crown, and ultimately, the classical horseshoe-shaped pattern of baldness: Previous research into male pattern hair loss, also termed androgenetic alopecia, has implicated multiple common genetic variants. Human geneticists from the University Hospital of Bonn (UKB) and by the Transdisciplinary Research Unit “Life & Health” of the University of Bonn have now performed a systematic investigation of the extent to which rare genetic variants may also contribute to this disorder. For this purpose, they analyzed the genetic sequences of 72,469 male participants from the UK Biobank project. The analyses identified five significantly associated genes, and further corroborated genes implicated in previous research. The results have now been published in the prestigious scientific journal Nature Communications.

Male-pattern hair loss is the most common form of hair loss in men, and is largely attributable to hereditary factors. Current treatment options and risk prediction are suboptimal, thus necessitating research into the genetic underpinnings of the condition. To date, studies worldwide have focused primarily on common genetic variants, and have implicated more than 350 genetic loci, in particular the androgen receptor gene, which is located on the maternally inherited X chromosome. In contrast, the contribution to this common condition of rare genetic variants has traditionally been assumed to be low. However, systematic analyses of rare variants have been lacking. “Such analyses are more challenging as they require large cohorts, and the genetic sequences must be captured base by base, e.g., through genome or exome sequencing of affected individuals,” explained first author Sabrina Henne, who is a doctoral student at the Institute of Human Genetics at the UKB and the University of Bonn. The statistical challenge lies in the fact that these rare genetic variants may be carried by very few, or even single, individuals. “That is why we apply gene-based analyses that first collapse variants on the basis of the genes in which they are located,” explained corresponding author PD Dr. Stefanie Heilmann-Heimbach, who is a research group leader at the Institute of Human Genetics at the UKB at the University of Bonn. Among other methods, the Bonn researchers used a type of sequence kernel association test (SKAT), which is a popular method for detecting associations with rare variants, as well as GenRisk, which is a method developed at the Institute of Genomic Statistics and Bioinformatics (IGSB) at the UKB and the University of Bonn.

Possible relevance of rare variants in male-pattern hair loss

The research involved the analysis of genetic sequences from 72,469 male UK Biobank participants. Within this extensive data set, Bonn geneticists, together with researchers from the IGSB and the Center for Human Genetics at the University Hospital Marburg, examined rare gene variants that occur in less than one percent of the population. Using modern bioinformatic and statistical methods, they found associations between male-pattern hair loss and rare genetic variants in the following five genes: EDA2R, WNT10A, HEPH, CEPT1, and EIF3F.

Prior to the analyses, EDA2R and WNT10A were already considered candidate genes, as based on previous analyses of common variants. “Our study provides further evidence that these two genes play a role, and that this occurs through both common and rare variants,” explained Dr. Stefanie Heilmann-Heimbach. Similarly, HEPH is located in a genetic region that has already been implicated by common variants, namely the EDA2R/Androgen receptor, which is a region that has consistently shown the strongest association with male-pattern hair loss in past association studies. “However, HEPH itself has never been considered as a candidate gene. Our study suggests that it may also play a role,” explained Sabrina Henne. “The genes CEPT1 and EIF3F are located in genetic regions that have not yet been associated with male-pattern hair loss. They are thus entirely new candidate genes, and we hypothesize that rare variants within these genes contribute to the genetic predisposition. HEPH, CEPT1, and EIF3F represent highly plausible new candidate genes, given their previously described role in hair development and growth.” Furthermore, the results of the study suggest that genes that are known to cause rare inherited diseases affecting both skin and hair (such as the ectodermal dysplasias) may also play a role in the development of male-pattern hair loss. The researchers hope that the puzzle pieces they have discovered will improve understanding of the causes of hair loss, and thus facilitate reliable risk prediction and improved treatment strategies.

The research was supported by funding from the Medical Faculty of the University of Bonn. Prof. Dr. Markus Nöthen, Director of the Institute of Human Genetics at UKB and co-author of the study, is a member of the Transdisciplinary Research Area (TRA) “Life and Health” at the University of Bonn. The publication costs in open access format were funded by the DEAL project of the University of Bonn.


Read More

Continue Reading

International

USD/CHF: Two-year yield surges as the risks grow to the US outlook

Republican Jim Jordan does not have enough votes to be elected House speaker in the first round of floor voting. Risk aversion was the early trade as hot…

Published

on

By

  • Republican Jim Jordan does not have enough votes to be elected House speaker in the first round of floor voting.
  • Risk aversion was the early trade as hot data fueled Fed rate hike bets
  • Investors await key Chinese data that could alleviate global growth concerns

USD/CHF been a tough trade over the last week as geopolitical concerns initially sent safe haven flows towards the franc, but resilient economic data prevented risk aversion from running wild.  The movement with Treasury yields are driving concerns that financial conditions are about to have a crippling impact on the economy.  The 5-year yield rose to the highest levels since 2007.  The 2-year Treasury yield also surged above the 5.22%, which is just below the current Fed’s Target range of 5.25%-5.50% .

The USD/CHF daily chart is showing prices tentatively breaking below the 200-day SMA and key support from the bullish trendline that has been in place since August.  Wall Street has had a strong start to earnings season, but it seems traders are growing confident that a slowdown is here given how high rates are going.  The risks to the US outlook are growing as the risk of more Fed rate hikes remains on the table and as Treasury market liquidity concerns remain a key focal point.   If bearish momentum resumes, downside could the 0.8950 region.

The rest of the week could see risk appetite attempt a comeback if Chinese data impresses. China will have the release of Q3 GDP and September activity data that could show their economic recovery is gaining traction.  Too much Fed speak is on the calendar but traders will focus on Thursday’s appearance by Fed Chair Powell. The dollar may fall if he supports the stance that more time is needed to decide if more tightening is needed to tame inflation.

 

Read More

Continue Reading

International

Best Penny Stocks To Buy Now? These 3 Are Moving Fast In October

3 Hot Penny Stocks To Watch This Week
The post Best Penny Stocks To Buy Now? These 3 Are Moving Fast In October appeared first on Penny Stocks to Buy,…

Published

on

Are you looking for the best penny stocks to buy now? Today might be your day…or not. These high-flying, low-priced stocks are well known for their innate ability to explode within a matter of minutes at times.

Imagine seeing a stock that trades for pennies on the dollar move less than $0.50 and score a 100% gain or more before lunch. It’s not science fiction; it’s trading penny stocks. Occurrences of scenarios like the one I just explained are not uncommon. But you need to understand the basics of trading, how to manage risk, and develop a trading style built for such volatility.

How To Trade Penny Stocks: A Brief Primer

Penny stocks are defined as stocks that trade for under $5 per share. They are typically issued by small companies that are not traded on major exchanges. The low price attracts investors looking for stocks that could see large percentage gains.

However, penny stocks are extremely volatile. Their prices fluctuate wildly and spreads between bid and ask prices are wide. Trading volumes are lower, making entering and exiting trades challenging. But that doesn’t mean they aren’t worth trading if you know what you’re doing.

Researching Penny Stocks Before Investing

Thorough research is crucial before investing in any penny stocks. Look at the company’s financial statements, operations, and recent news. Search for analyst coverage and reports if they exist. Check investor forums and social media to gauge current sentiment. This helps avoid buying into potential pump-and-dump schemes or companies already in decline.

Starting with Paper Trading

Begin by paper trading imaginary penny stock purchases. Track how your simulated trades would perform without risking real money. Open a practice trading account with an online broker to experience the real market action first-hand. This lets you learn the ropes before using actual capital.

3 Top Penny Stocks to Buy According To Insiders In October

Beginning to Trade with Real Money

When ready to trade real money, start very small. Only invest what you can afford to lose entirely. Limit penny stock positions to a maximum of 5% of your overall portfolio. Use stop losses on all trades to restrict potential losses. Focus on stocks with daily trading volumes above 500,000 shares for better liquidity. Monitor bid-ask spreads and use limit orders for better trade execution.

Staying Up to Date on Stocks You Own

Keep up with latest news, SEC filings, and developments related to stocks you own or are interested in. Set price alerts and follow stock message boards and social media feeds. Negative rumors or bad news can quickly tank penny stocks. Identify positive catalysts driving price spikes to find ideal entry points.

news penny stocks

Finding Penny Stocks with Momentum

Search for penny stocks breaking out to new 52-week highs on heavy trading volume. This signals upside momentum. Screen for stocks with earnings growth, analyst upgrades, or other improving fundamentals. Technical analysis can also help identify bullish chart patterns about to break out. Focus on quality companies in higher OTC Market tiers.

Using Caution and Limiting Risks

In summary, limit penny stock positions to a small portion of invested capital due to the substantial risks involved. Use stop losses, limit orders, paper trading, and small position sizes to minimize downside. With caution, penny stocks can provide opportunities for short-term gains as part of a diversified portfolio.

Best Penny Stocks To Buy Now? Here Are 3 To Watch

Virgin Galactic Holdings (SPCE)

Space stocks were once a popular topic, but the trend cooled off significantly with the shift in market sentiment. The latest risk-on environment, however, has brought interest back to companies in the niche. Virgin Galactic most notably has taken an appeal from investors as the company continues launching civilians into space.

4 Hot Penny Stocks To Watch With The Stock Market Up Today

Earlier this month, the company completed its fifth successful human space mission in the last five months. Michael Colglazier, CEO of Virgin Galactic, said: “Our teams in New Mexico and California have delivered on our monthly spaceflight objectives. Three new astronauts journeyed to space today and brought back incredible memories and stories of their experience above the Earth. These early missions with our initial ship, VSS Unity, have informed and confirmed the design and maintenance objectives for our Delta class spaceships, and the production tooling for those ships is on track to commence later in the fourth quarter.”

This week, as the market has risen, so have shares of SPCE stock. While it’s a positive for the company following a long stint of selling, Virgin is still hovering around 52-week lows.

bluebird bio Inc. (BLUE)

Earnings season is in full swing and showing the true colors of the companies reporting. bluebird bio will be reporting in a few weeks. In its last financial update, the company beat EPS estimates but missed on sales expectations. bluebird said that its commercial launch of ZYNTEGLO and SKYSONA remained strong and that a Biologics License Application for its lovo-cel in sickle cell disease was accepted for priority review by the FDA.

Andrew Obenshain, chief executive officer, bluebird bio commented, “Additionally, with the ongoing FDA review of lovo-cel and potential approval by the end of this year, bluebird is preparing for our largest opportunity yet to impact the lives of patients and families – a gene therapy for individuals living with sickle cell disease in the US.”

The FDA communicated in August that an advisory committee meeting will not be scheduled for lovo-cel gene therapy for sickle cell disease. The Agency previously accepted the lovo-cel Biologics Licensing Application (BLA) for Priority Review and set a Prescription Drug User Fee Act (PDUFA) goal date of December 20, 2023. In the interim, analysts have also begun picking up more coverage on BLUE stock. This week Cantor Fitzgerald initiated coverage with a Neutral rating. Last month HSBC initiated coverage with a Buy rating and set a BLUE stock forecast price target of $4.21.

EQRx Inc. (EQRX)

Shares of EQRx continue rising, thanks to acquisition news. The company is developing a platform to tackle some of the most prevalent disease areas, including candidates for breast cancer. It also has announced M&A developments in the works.

The company and Revolution Medicines, Inc. (NASDAQ: RVMD) announced a definitive agreement. The all-stock transaction is expected to add more than $1 billion in net cash to Revolution Medicines’ balance sheet.

Can You Still Make Money Trading Penny Stocks? 3 Tips

In an update, Melanie Nallicheri, president and chief executive officer of EQRx, explained, “With its pioneering portfolio of RAS(ON) inhibitors, designed to defeat RAS-addicted cancers which represent 30% of all human cancers, Revolution Medicines has the opportunity to address one of the largest areas of unmet need in oncology. Deploying our significant capital not only enhances this important vision, it also provides a compelling opportunity for our stockholders to participate in the upside potential of both near-term and long-term value catalysts.”

The deal is expected to close in November. As the date nears, so does speculative momentum in EQRX stock.

The post Best Penny Stocks To Buy Now? These 3 Are Moving Fast In October appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Read More

Continue Reading

International

Air Corsica to digitalise IFE offer with Moment solution for a “memorable and connected cabin experience”

The following article was published by Future Travel Experience
Air Corsica has selected Moment (an exhibitor at FTE APEX Asia Expo, 8-9 November 2023,…

Published

on

The following article was published by Future Travel Experience

Air Corsica has selected Moment (an exhibitor at FTE APEX Asia Expo, 8-9 November 2023, Singapore) to install its inflight entertainment system, the Flymingo Box, onboard the airline’s fleet by end-2023.

Air Corsica has selected Moment (an exhibitor at FTE APEX Asia Expo, 8-9 November 2023, Singapore) to install its inflight entertainment system, the Flymingo Box, onboard the airline’s fleet by the end of 2023.

Air Corsica has selected Moment (an exhibitor at FTE APEX Asia Expo, 8-9 November 2023, Singapore) to install its inflight entertainment system, the Flymingo Box, onboard the airline’s fleet by the end of 2023.

Designed as a compact, battery-operated server, the Flymingo box has the capacity to provide a video stream to 100 passengers simultaneously. The modular white-label solution allows airlines to customise their digital inflight service by adding or removing modules, such as entertainment, inflight magazine, e-commerce, satisfaction surveys etc.

“With the deployment of Moment’s innovative entertainment solution, we are reinforcing our sustainable commitments, which are part of our ‘Ambizione 2025’ strategy,” said Luc Bereni, Chairman of Air Corsica’s Management Board. “Simple to use, with an attractive design, we look forward to our customers enjoying this new customer service.”

Air Corsica has chosen to offer a rich entertainment platform with a large catalogue of selected content (movies, press, podcasts, games, etc). To further enhance the experience, Moment has partnered with Allindi, a Corsican VOD platform, to offer a 100% Corsican movie catalogue. Passengers will also have access to a moving map, inflight magazine and a satisfaction survey.

“The improvement of Air Corsica’s passenger experience is significant for the airline and we are proud to contribute to it with our solution,” said Tanguy Morel, CEO & co-founder, Moment. “In a context where passengers no longer expect to just travel but to have a great experience, we are committed to working alongside airlines to enable them to offer this memorable and connected cabin experience.”

Article originally published here:
Air Corsica to digitalise IFE offer with Moment solution for a “memorable and connected cabin experience”

Read More

Continue Reading

Trending